Showing 10,001 - 10,020 results of 226,405 for search '(( a ((((mean decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a latest decrease ))', query time: 1.74s Refine Results
  1. 10001

    Data Sheet 8_Comparative transcription profiles of Candidatus Accumulibacter and Propionivibrio under phosphate limitation in sequencing batch reactors.xlsx by Laëtitia Cardona (8790653)

    Published 2025
    “…Two sequencing batch reactors were operated with different carbon sources to enrich for different populations of Accumulibacter. After decreasing the influent phosphate concentration, carbon removal performance was maintained while anaerobic phosphate release dropped dramatically, suggesting a shift from a phosphate-accumulating to a glycogen-accumulating metabolism. …”
  2. 10002
  3. 10003
  4. 10004
  5. 10005
  6. 10006
  7. 10007
  8. 10008

    Data_Sheet_1_MxB Disrupts Hepatitis C Virus NS5A–CypA Complex: Insights From a Combined Theoretical and Experimental Approach.PDF by Quanjie Li (447626)

    Published 2022
    “…A 28% decrease in CypA–NS5A binding affinity was observed in the presence of MxB, suggesting a weakened CypA–NS5A association upon binding of MxB to NS5A, which may contribute to the MxB-mediated inhibitory effect on the formation of CypA–NS5A complex. …”
  9. 10009
  10. 10010
  11. 10011
  12. 10012
  13. 10013

    NBCe1 and NBCe2 protein and mRNA expression in hRPTCs carrying wild-type (WT) or homozygous variant (HV) <i>SLC4A5</i>. by John J. Gildea (845025)

    Published 2018
    “…<b>D) <i>SLC4A4</i> mRNA.</b> <i>SLC4A4</i> mRNA is decreased following an increase in intracellular sodium (monensin, 1 μmol/L, 24 h) (↑Na<sup>+</sup>) only in WT <i>SLC4A5</i> hRPTCs (N = 9, *P<0.05 vs. …”
  14. 10014
  15. 10015

    Typical time-traces of a subject walking at ~0.83 m s<sup>-1</sup> (3 km h<sup>-1</sup>) on a -9° slope (left column), on the level (middle column) and on a +9° slope (right column... by Arthur H. Dewolf (4537918)

    Published 2017
    “…<p><b>Top panels:</b> Mechanical energy-time curves of the COM during a stride. Strides are delimited by the maximal fore-aft velocity of the COM when the right foot is in front. …”
  16. 10016
  17. 10017

    Table_2_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX by Emilie Faivre (5507582)

    Published 2018
    “…Interestingly, MSX-3 treatment led to a significant decrease of Aβ1-42 levels in the cortex of APP/PS1dE9 animals, while Aβ1-40 increased, thereby strongly affecting the Aβ1-42/Aβ1-40 ratio. …”
  18. 10018

    Table_1_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX by Emilie Faivre (5507582)

    Published 2018
    “…Interestingly, MSX-3 treatment led to a significant decrease of Aβ1-42 levels in the cortex of APP/PS1dE9 animals, while Aβ1-40 increased, thereby strongly affecting the Aβ1-42/Aβ1-40 ratio. …”
  19. 10019

    Table_3_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX by Emilie Faivre (5507582)

    Published 2018
    “…Interestingly, MSX-3 treatment led to a significant decrease of Aβ1-42 levels in the cortex of APP/PS1dE9 animals, while Aβ1-40 increased, thereby strongly affecting the Aβ1-42/Aβ1-40 ratio. …”
  20. 10020

    Table_4_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX by Emilie Faivre (5507582)

    Published 2018
    “…Interestingly, MSX-3 treatment led to a significant decrease of Aβ1-42 levels in the cortex of APP/PS1dE9 animals, while Aβ1-40 increased, thereby strongly affecting the Aβ1-42/Aβ1-40 ratio. …”